Lyell Immunopharma LYEL
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 20.06 | 183.25 | -1.1 | -44,261 | -24 | |
| 2025Q4 | 30.78 | 90.71 | -7.68 | -127,644 | -141 | |
| 2025Q3 | 16.24 | 95.9 | -2.13 | -37,253 | -39 | |
| 2025Q2 | 8.84 | 110.44 | -2.88 | -47,140 | -43 | |
| 2025Q1 | 10.76 | 109.91 | -3.54 | -57,367 | -52 | |
| 2024Q4 | 12.8 | 104.8 | -14.4 | -201,147 | -192 | |
| 2024Q3 | 27.6 | 113.28 | -3.4 | -50,505 | -45 | |
| 2024Q2 | 29 | 112.48 | -3.6 | -51,528 | -46 | |
| 2024Q1 | 44.6 | 91.61 | -4.8 | -55,575 | -61 | |
| 2023Q4 | 38.8 | 112.43 | -4.1 | -59,508 | -53 | |
| 2023Q3 | 29.4 | 116.1 | -4.2 | -59,039 | -51 | |
| 2023Q2 | 63.6 | 103.15 | -5 | -65,905 | -64 | |
| 2023Q1 | 47.2 | 93.42 | -5.4 | -62,556 | -67 | |
| 2022Q4 | 69.4 | 176.06 | -0.6 | -14,784 | -8 | |
| 2022Q3 | 146.6 | 94.57 | -5.6 | -66,437 | -70 | |
| 2022Q2 | 130.4 | 102.58 | -3 | -37,261 | -36 | |
| 2022Q1 | 101 | 100.63 | -5.6 | -68,576 | -68 | |
| 2021Q4 | 154.8 | 56.79 | -3.6 | -47,538 | -84 | |
| 2021Q3 | 296 | 100.59 | 45 | -49,161 | -49 | |
| 2021Q2 | 324.8 | 100.18 | -14.4 | -62,707 | -63 |